Breaking News
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
Ajinomoto, XL-protein Forge Strategic Alliance
Ajinomoto will apply its Corynex expression system with XL-protein's PASylation technology to develop a series of therapeutic compounds12.18.18
-
Biosimilars | Breaking News | Drug Development | Industry News
Alvotech, Fuji Pharma Expand Biosimilars Alliance
Fuji invests $50 million in Alvotech, expands development and commercialization of biosimilars in Japan12.18.18
-
Bio News | Collaborations & Alliances | Drug Discovery | Industry News | R&D
Roquette & Thermo Fisher Enter Distribution Deal
For the Roquette portfolio of pharmaceutical ingredients in the United States and Canada12.18.18
-
Breaking News | Drug Development | Industry News
Selexis, Teneobio Enter Second Services Agreement
Will utilize Selexis’ SUREtechnology Platform to develop research cell banks for three additional preclinical candidates12.18.18
-
Drug Development | Trials & Filings
Amgen’s Nplate Approved for ITP
Phase III study shows overall platelet response was increased with the Nplate group (71 percent) compared with placebo12.17.18
-
Breaking News | Drug Development | Industry News
Lilly Acquires Hydra Biosciences’ Pain Asset
Preclinical program of TRPA1 antagonists being studied for the potential treatment of chronic pain12.17.18
-
Breaking News | cGMP Manufacture | Drug Development | Industry News
Rentschler Biopharma Buys U.S. Mfg. Site from Shire
Will leverage the development and manufacturing site for CDMO services12.17.18
-
Bio News | Clinical Trials | Industry News | R&D
Neurotrope Announces Publication of Phase 2 Alzheimer's Study
The multidose, exploratory trial was to evaluate Bryostatin-1 as a treatment of cognitive deficits in moderate to severe Alzheimer's disease12.17.18
-
Breaking News | Promotions & Moves
Executive Moves: AbbVie
Changes aim to streamline organizational structure and support long-term growth strategy12.17.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Proteostasis & Genentech Sign Licensing Deal
For rights to potential therapeutic small molecule modulators of an undisclosed target within the proteostasis network12.17.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Discovery | Industry News | Laboratory Testing | R&D
Alkermes, Biogen Submit NDA to FDA
For diroximel fumarate (BIIB098), a novel oral fumarate in development for the treatment of relapsing forms of multiple sclerosis12.17.18
-
Breaking News | Drug Development | Industry News
Astellas Pharma Acquires Potenza Therapeutics
Successful collaboration results in three INDs with the potential to treat various cancers12.17.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
KIO, Pfizer Enter Research Collaboration
To develop RIG-I agonist immunotherapies for the treatment of cancer12.17.18
-
Breaking News | Promotions & Moves
-
Bio News | Collaborations & Alliances | Drug Development | Industry News | R&D
Orchard & SIRION Enter License Agreement
SIRION to provide Orchard with a license to its proprietary lentiviral transduction enhancer LentiBOOST™12.14.18
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
CTI BioPharma Corp. Restructures
Workforce reductions have been implemented that impact approximately 50 percent of the company's employees12.14.18
-
Breaking News | Clinical Trials | CRO News | Drug Development | Promotions & Moves
PPD Adds New Therapeutic Area Leaders
Enhances drug development capabilities in cardiovascular disease, critical care, endocrinology, metabolism and diabetes12.13.18
-
Collaborations & Alliances
Janssen, OHCA Enter LAIs Contract
Results-based contract focuses on long-acting injectable schizophrenia medicines12.13.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Q BioMed, SRI Enter ASD Collaboration
To provide formulation development, preclinical development, and early clinical manufacturing of QBM-001 for non-verbal or minimally verbal autistic children12.13.18
-
Bio News | Industry News | Promotions & Moves
Rentschler Biopharma Appoints Innovation SVP
Dr. Jesús Zurdo will provide scientific leadership for development and manufacturing services from cell-line development through to final product manufacturing12.13.18
